NCCTG N08CA (Alliance): The use of Glutathione for Prevention of Paclitaxel/Carboplatin Induced Peripheral Neuropathy: A Phase III Randomized, Double-Blind Placebo-Controlled Study
      QxMD      Google Scholar   
Citation:
Cancer vol 120 (12) 1890-1897
Year:
2014
Type:
Manuscript
Funding:
NCTN
Endpoint:
Primary
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
pmc-release
Note:
Methodological:
No
Biospecimen:
No
SDC:
No
Book Volume:
3
Parents:
None
Children:
None
Program:
CCP
Primary Committee:
Symptom Inter
Sec. Committees:
   
Pharmas:
 
Grants:
CA-37, 404, U10 CA035267, CA33601, CA-35, 090, U10 CA052352, CA-63, 848, N01 CA035431, U10 CA035269, 269, CA-25, 224, 272, K05 CA124477, 195, U10 CA031946, U10 CA033601, U10 CA037404, 448, U10 CA035448, U10 CA063848, 267, U10 CA035195, N01 CA063844, U10 CA035272, P30 CA015083, U10 CA063849, CA-52, 352, U10 CA035431, 849, U10 CA025224, 844, U10 CA035090, CA31946, 103, U10 CA063844, 431, U10 CA035103  
Corr. Author:
 
Authors:
                       
Networks:
 
Study
NCCTG-N08CA
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
3
Keywords:
glutathione, chemotherapy induced peripheral neuropathy, prevention, paclitaxel, carboplatin